136 related articles for article (PubMed ID: 36897102)
21. [The frequency of malignant disease in cytological group of suspected cancer (ultrasound-guided fine-needle aspiration biopsy of nonpalpable thyroid nodules)].
Miseikyte-Kaubriene E; Ulys A; Trakymas M
Medicina (Kaunas); 2008; 44(3):189-94. PubMed ID: 18413985
[TBL] [Abstract][Full Text] [Related]
22. Expression Levels of miR-30a-5p in Papillary Thyroid Carcinoma: A Comparison Between Serum and Fine Needle Aspiration Biopsy Samples.
Igci YZ; Ozkaya M; Korkmaz H; Bozgeyik E; Bayraktar R; Ulasli M; Erkilic S; Eraydin A; Oztuzcu S
Genet Test Mol Biomarkers; 2015 Aug; 19(8):418-23. PubMed ID: 26047355
[TBL] [Abstract][Full Text] [Related]
23. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic accuracy of fine needle aspiration biopsy for detection of malignancy in pediatric thyroid nodules: protocol for a systematic review and meta-analysis.
Lai SW; Roberts DJ; Rabi DM; Winston KY
Syst Rev; 2015 Sep; 4():120. PubMed ID: 26399232
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.
Vriens MR; Weng J; Suh I; Huynh N; Guerrero MA; Shen WT; Duh QY; Clark OH; Kebebew E
Cancer; 2012 Jul; 118(13):3426-32. PubMed ID: 22006248
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration.
Agretti P; Ferrarini E; Rago T; Candelieri A; De Marco G; Dimida A; Niccolai F; Molinaro A; Di Coscio G; Pinchera A; Vitti P; Tonacchera M
Eur J Endocrinol; 2012 Sep; 167(3):393-400. PubMed ID: 22728346
[TBL] [Abstract][Full Text] [Related]
27. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.
Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ
Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693
[TBL] [Abstract][Full Text] [Related]
28. Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience.
Bongiovanni M; Molinari F; Eszlinger M; Paschke R; Barizzi J; Merlo E; Giovanella L; Fasolini F; Cattaneo F; Ramelli F; Mazzucchelli L; Frattini M
Cytopathology; 2015 Oct; 26(5):288-96. PubMed ID: 25487739
[TBL] [Abstract][Full Text] [Related]
29. ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours.
Karger S; Krause K; Gutknecht M; Schierle K; Graf D; Steinert F; Dralle H; Führer D
Br J Cancer; 2012 Jan; 106(3):562-8. PubMed ID: 22223087
[TBL] [Abstract][Full Text] [Related]
30. ThyroSeq v3 for Bethesda III and IV: An institutional experience.
Desai D; Lepe M; Baloch ZW; Mandel SJ
Cancer Cytopathol; 2021 Feb; 129(2):164-170. PubMed ID: 33030808
[TBL] [Abstract][Full Text] [Related]
31. Performance of repeat cytology with reflex ThyroSeq genomic classifier for indeterminant thyroid cytology.
O'Conor CJ; Dash RC; Jones CK; Jiang XS
Cancer Cytopathol; 2022 Jun; 130(6):469-476. PubMed ID: 35045202
[TBL] [Abstract][Full Text] [Related]
32. Next-Generation Sequencing Identifies a Highly Accurate miRNA Panel That Distinguishes Well-Differentiated Thyroid Cancer from Benign Thyroid Nodules.
Mazeh H; Deutch T; Karas A; Bogardus KA; Mizrahi I; Gur-Wahnon D; Ben-Dov IZ
Cancer Epidemiol Biomarkers Prev; 2018 Aug; 27(8):858-863. PubMed ID: 30049841
[No Abstract] [Full Text] [Related]
33. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.
Labourier E; Shifrin A; Busseniers AE; Lupo MA; Manganelli ML; Andruss B; Wylie D; Beaudenon-Huibregtse S
J Clin Endocrinol Metab; 2015 Jul; 100(7):2743-50. PubMed ID: 25965083
[TBL] [Abstract][Full Text] [Related]
34. Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples.
Mazeh H; Mizrahi I; Halle D; Ilyayev N; Stojadinovic A; Trink B; Mitrani-Rosenbaum S; Roistacher M; Ariel I; Eid A; Freund HR; Nissan A
Thyroid; 2011 Feb; 21(2):111-8. PubMed ID: 21275764
[TBL] [Abstract][Full Text] [Related]
35. An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.
McIver B; Castro MR; Morris JC; Bernet V; Smallridge R; Henry M; Kosok L; Reddi H
J Clin Endocrinol Metab; 2014 Nov; 99(11):4069-77. PubMed ID: 24780044
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA signature in thyroid fine needle aspiration cytology applied to "atypia of undetermined significance" cases.
Shen R; Liyanarachchi S; Li W; Wakely PE; Saji M; Huang J; Nagy R; Farrell T; Ringel MD; de la Chapelle A; Kloos RT; He H
Thyroid; 2012 Jan; 22(1):9-16. PubMed ID: 22136206
[TBL] [Abstract][Full Text] [Related]
37. Malignancy risk assessment in adenomatoid nodules and suspicious follicular lesions of the thyroid obtained by fine needle aspiration cytology.
Dabelić N; Matesa N; Matesa-Anić D; Kusić Z
Coll Antropol; 2010 Jun; 34(2):349-54. PubMed ID: 20698101
[TBL] [Abstract][Full Text] [Related]
38. Comparison of thyroid fine needle aspiration biopsy results before and after implementation of Bethesda classification.
Ozdemir D; Bestepe N; Faki S; Kilicarslan A; Parlak O; Ersoy R; Cakir B
Cytopathology; 2017 Oct; 28(5):400-406. PubMed ID: 28727204
[TBL] [Abstract][Full Text] [Related]
39. A core needle biopsy provides more malignancy-specific results than fine-needle aspiration biopsy in thyroid nodules suspicious for malignancy.
Hakala T; Kholová I; Sand J; Saaristo R; Kellokumpu-Lehtinen P
J Clin Pathol; 2013 Dec; 66(12):1046-50. PubMed ID: 23863219
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of miR-7-5p and miR-548ar-5p predicts malignancy in indeterminate thyroid nodules negative for BRAF and RAS mutations.
Macerola E; Poma AM; Proietti A; Rago T; Romani R; Vignali P; Ugolini C; Torregrossa L; Basolo A; Santini F; Basolo F
Endocrine; 2022 Jun; 76(3):677-686. PubMed ID: 35347579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
